Cited 0 time in
- Title
- In vitro antioxidant and anti-neuroinflammatory effects of Elsholtzia blanda (Benth.) Benth
- Author(s)
- Yeo Dae Yoon; K K Shrestha; S H Baek
- Bibliographic Citation
- Life-Basel, vol. 15, no. 6, pp. 983-983
- Publication Year
- 2025
- Abstract
- Elsholtzia blanda (Benth.) Benth. (EBB) is a traditional plant in Nepal with bioactive properties, including antioxidant, cytotoxic, and antitumor activities. In this study, a methanol EBB extract was tested to evaluate the anti-inflammatory effect against lipopolysaccharide (LPS)-induced microglial (BV2) cells. EBB effectively suppressed LPS-induced nitric oxide production and inhibited the secretion of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6. In LPS-stimulated BV2 cells, EBB significantly inhibited inducible nitric oxide synthase (iNOS), TNF-α, IL-6, IL-1β, IL-8, IL-18, and IL-10 mRNA expression in a concentration-dependent manner. In particular, EBB significantly reduced the protein expression of iNOS and cyclooxygenase-2, which were upregulated by LPS. Further, EBB could alleviate the inflammatory response in microglia by suppressing the phosphorylation of mitogen-activated protein kinases. EBB also attenuated LPS-induced reactive oxygen species (ROS) in BV2 cells. In addition, EBB enhanced heme oxygenase-1 (HO-1) protein and mRNA expression. The present results show that an EBB extract could effectively suppress the neuroinflammatory response induced by LPS in BV2 cells. Accordingly, an EBB extract is a promising preventive agent against diseases involving neuroinflammatory responses.
- Keyword
- Elsholtzia blanda (Benth.) Benth. (EBB)AntioxidantAnti-neuroinflammatory effectBV2 microglia cellProinflammatory cytokineReactive oxygen species (ROS)
- ISSN
- 2075-1729
- Publisher
- MDPI
- Full Text Link
- http://dx.doi.org/10.3390/life15060983
- Type
- Article
- Appears in Collections:
- 1. Journal Articles > Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.